Myasthenia Gravis, Generalized
Myasthenia Gravis, Generalized
Explore linked clinical trials. Standard reference: MESH:M033525517 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE) | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 3 | 2026-09-25 | NCT07647510 | |
| Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Not stated | 2026-09-16 | NCT06909253 | |
| A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 2 | 2026-09-11 | NCT07501702 | |
| Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 4 | 2026-09-03 | NCT07072988 | |
| AXIS MG Patient Registry | Disease Attributes, Disease Progression, Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis, Myasthenia Gravis, Generalized, Myasthenia Gravis, Ocular, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Not stated | 2026-08-17 | NCT07761026 | |
| Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Active, not recruiting | Phase 2 | 2026-08-14 | NCT04146051 | |
| A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, generalized myasthenia gravis, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Active, not recruiting | Phase 3 | 2026-08-10 | NCT06298552 | |
| Study of Aritinercept in Patients With Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 1 / Phase 2 | 2026-08-03 | NCT07596901 | |
| A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC) | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Active, not recruiting | Phase 2 | 2026-07-27 | NCT06282159 | |
| The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Active, not recruiting | Phase 1 | 2026-05-27 | NCT06958939 | |
| Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research | Axial Spondyloarthritis, Bacterial Infections and Mycoses, Borrelia infectious disease, Brain Injuries, Traumatic, CNS demyelinating autoimmune disease, COVID-19, Chronic Disease, Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Coronaviridae Infections, Craniocerebral Trauma, Crohn disease, Digestive System Diseases, Disease Attributes, Disorders of Excessive Somnolence, Dyssomnias, Ehlers-Danlos syndrome, Fatigue, Feeding and Eating Disorders, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemic and Lymphatic Diseases, Infections, Inflammation, Lyme disease, Mast Cell Activation Disorders, Mental Fatigue, Myasthenia Gravis, Generalized, Neoplasms by Site, Neuroinflammatory Diseases, Nidovirales infectious disease, Nutritional and Metabolic Diseases, Orthocoronavirinae infectious disease, PANDAS, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, Signs and Symptoms, Skin Abnormalities, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Sleep Disorders, Intrinsic, Spondylarthritis, Spondylarthropathies, Stress Disorders, Traumatic, Tourette syndrome, Urogenital Diseases, acute stress disorder, ankylosing spondylitis, ankylosis, anorexia nervosa, anxiety disorder, arthritic joint disease, arthropathy, autoimmune disease, autoimmune disorder of the nervous system, autoimmune encephalitis, autonomic nervous system disorder, avoidant/restrictive food intake disorder, bacterial infectious disease, basal ganglia disorder, bone disorder, brain disorder, brain injury, bulimia nervosa, cardiovascular disorder, celiac disease, central nervous system disorder, colitis, colonic disorder, combat disorder, connective tissue disorder, demyelinating disease, depressive disorder, digestive system disorder, encephalitis, encephalomyelitis, endometriosis, female reproductive system disorder, fibromyalgia, gastroenteritis, generalized anxiety disorder, gram-negative bacterial infections, gram-positive bacterial infections, headache disorder, hematologic disorder, hemorrhagic disease, hereditary disease, hereditary skin disorder, hypnic headache, immune system disorder, inflammatory bowel disease, inherited neurodegenerative disorder, injury, intestinal disorder, juvenile idiopathic arthritis, long COVID-19, lung disorder, malabsorption syndrome, mast cell activation syndrome, metabolic disease, migraine disorder, mood disorder, movement disorder, multiple sclerosis, muscle tissue disorder, musculoskeletal system disorder, myalgic encephalomeyelitis/chronic fatigue syndrome, myasthenia gravis, narcolepsy, neoplasm, nervous system disorder, nervous system injury, neurodegenerative disease, neurodevelopmental disorder, neuromuscular disease, neuromuscular junction disease, obsessive-compulsive disorder, orthostatic intolerance, paraneoplastic syndrome, pediatric acute-onset neuropsychiatric syndrome, phobic disorder, pneumonia, post-traumatic stress disorder, post-treatment Lyme disease syndrome, primary dysautonomia, psoriasis, psoriatic arthritis, psychiatric disorder, respiratory system disorder, respiratory tract infectious disorder, rheumatic disorder, rheumatic fever, skin disorder, sleep-wake disorder, social phobia, spirochaetales infections, spondylitis, streptococcal infection, tic disorder, tick-borne infectious disease, ulcerative colitis, vascular disorder, vascular hemostatic disease, vector-borne disease, vertebral column disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-01-22 | NCT04806620 | |
| Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360 | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Not yet recruiting | Not applicable | 2026-01-07 | NCT07323316 | |
| Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Not yet recruiting | Not stated | 2025-11-04 | NCT07224386 | |
| Markers of Favorable Response to Complement Inhibitors Therapy | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Not stated | 2025-08-01 | NCT06455709 | |
| Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis | Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Phase 2 | 2025-05-01 | NCT05067348 | |
| Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Myasthenia Gravis, Generalized, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute transverse myelitis, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, cranial nerve neuropathy, demyelinating disease, eye disorder, immune system disorder, multiple sclerosis, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Not yet recruiting | Early phase 1 | 2025-01-01 | NCT06485232 | |
| Myasthenia Gravis Foundation of America Global MG Patient Registry | Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis, Myasthenia Gravis, Generalized, Myasthenia Gravis, Ocular, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, autoimmune disease, autoimmune disorder of the nervous system, immune system disorder, myasthenia gravis, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, paraneoplastic syndrome | Recruiting | Not stated | 2024-09-27 | NCT06617741 |